Implications for Managed Care Pharmacy from the 2020 Medicare Part D Call Letter and Star Ratings Release
Webinar Recorded on February 20, 2019
Join AMCP for a review of the provisions contained in the draft 2020 CMS Medicare Part D Call Letter that was released by the Centers for Medicare and Medicaid Services (CMS) on January 30, 2019. This webinar will take a deep dive into the policy provisions of importance to managed care pharmacy including generic and specialty tier composition, medication therapy management, opioid management, and Star Ratings for 2020 and beyond. Please join us and help inform AMCP’s comments to CMS!
View a summary of the proposed provisions. Comments to CMS on the Draft Call Letter are due on March 1, 2019.
- Afton Wagner, PharmD
Director, Regulatory Affairs
Academy of Managed Care Pharmacy (AMCP)
- Brian Roland, PharmD, BCACP
Manager, Clinical Pharmacy